RPTX - Repare Therapeutics Inc
IEX Last Trade
2.94
-0.070 -2.381%
Share volume: 76,235
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.01
-0.07
-2.33%
Summary score
31%
Profitability
25%
Dept financing
5%
Liquidity
75%
Performance
33%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.24%
Return on assets
-6.11%
Return on sales
-3946.28%
Return on invested capital
197.36%
Total debt ratio
21.68%
Debt ratio change over timeo
-0.8%
Current Ratio
9.15%
Quick Ratio
9.15%
Cash Position Ratio
8.79%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5.12%
Return on assets
-6.38%
Return on sales
-508.98%
Return on invested capital
28.81%
Total debt ratio
16.36%
Debt ratio change over timeo
-0.94%
Current Ratio
6.42%
Quick Ratio
6.42%
Cash Position Ratio
5.96%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
5.67%
Return on assets
4.11%
Return on sales
20.64%
Return on invested capital
-59.41%
Total debt ratio
11.83%
Debt ratio change over time
-0.88%
Current Ratio
8.33%
Quick Ratio
8.33%
Cash Position Ratio
7.75%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.01%
Return on assets
-101.99%
Return on sales
-1837.56%
Return on invested capital
-40.39%
Total debt ratio
-80.3%
Debt ratio change over time
-0.8%
Current Ratio
4.81%
Quick Ratio
4.81%
Cash Position Ratio
4.57%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RPTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.24% | 13.79% | 34.47% | 7.43% |
| Return on assets | -6.11% | 2.76% | 3.15% | 5.62% |
| Return on sales | -3946.28% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 197.36% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 21.68% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.8% | 308.97% | -6.99% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 6.42% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.42% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.96% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 12% | 28% |
| Short-term ratios | RPTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.12% | 13.77% | 13.25% | 3.8% |
| Return on assets | -6.38% | 2.43% | 1.89% | 3.09% |
| Return on sales | -508.98% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 28.81% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 67% | 62% | 65% |
| Total debt ratio | 16.36% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.94% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 6.42% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.42% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.96% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 21% | 51% |